ToxGenSolutions (TGS) applies toxicogenomic approaches on human health problems to provide the customer with epigenetic biomarker fingerprints for application in novel, more accurate, methods for the particular diagnosis of their need.
TGS aims to develop novel and innovative epigenetic profiles hallmarking high-impact chronic and rare neurodevelopmental diseases to serve as early, preclinical, diagnostic verdicts of a disease.
With the development of these novel tools, TGS aims to bridge the frequently large gap towards disease progression and therapeutic intervention.
TGS provides novel epigenetic diagnostic methods for the early identification of pressing high-impact pathologies including cancer, neurodegeneration and immune-dysfunction, before irreversible disease-specific alterations in patient physiology have occurred. By doing this, we aim to provide an optimal perspective for patient healthcare as well as follow-up programs and preventative therapeutic interventions.
Company Details
- Founded
- -
- Address
- Oxfordlaan 70, Maastricht,limburg 6229 Ev,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://toxgen.solutions
- Keywords
- diagnostics, Therapeutics, Neuroscience.
- HQ
- Maastricht, Limburg
Toxgensolutions Bv (Tgs) Questions
Toxgensolutions Bv (Tgs)'s website is https://toxgen.solutions
Toxgensolutions Bv (Tgs)'s LinkedIn profile is https://nl.linkedin.com/company/toxgensolutions-bv
Toxgensolutions Bv (Tgs)'s industry is
Biotechnology Research
Toxgensolutions Bv (Tgs)'s top competitors are
Medace Bv,
Brightlands Maastricht Health Campus Bv,
Mindahead,
C. Light Technologies, Inc.,
Laboratoire Toxgen,
Stem Pharm,
Atro Medical Bv,
Poiesy B.v.,
Lonza,
Avalanche Medical B.v..
Toxgensolutions Bv (Tgs)'s categories are Biotechnology Research
Toxgensolutions Bv (Tgs)'s founding year is 2015
